Repligen
RGEN
#2045
Rank
โ‚น834.29 B
Marketcap
โ‚น14,821
Share price
-0.47%
Change (1 day)
23.03%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): โ‚น2.30 Billion

According to Repligen 's latest financial reports the company's current earnings are โ‚น0.70 Billion. In 2024 the company made an earning of -โ‚น0.57 Billion a decrease over its 2023 earnings that were of โ‚น4.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น2.30 B-507.1%
2024 -โ‚น0.57 Billion-113.01%
2023 โ‚น4.35 B-78.01%
2022 โ‚น19.79 B33.37%
2021 โ‚น14.83 B131.52%
2020 โ‚น6.40 B101.31%
2019 โ‚น3.18 B25.93%
2018 โ‚น2.52 B105.61%
2017 โ‚น1.22 B-11.46%
2016 โ‚น1.38 B14.91%
2015 โ‚น1.20 B20.26%
2014 โ‚น1.00 B-51.49%
2013 โ‚น2.07 B90.98%
2012 โ‚น1.08 B
2010 โ‚น15.72 M-103.81%
2009 -โ‚น0.42 Billion-223.84%
2008 โ‚น0.33 B
2006 -โ‚น0.23 Billion229.64%
2005 -โ‚น67.82 Million-89.16%
2004 -โ‚น0.63 Billion-16.86%
2003 -โ‚น0.76 Billion88.72%
2002 -โ‚น0.4 Billion-27.88%
2001 -โ‚น0.56 Billion-1.74%
2000 -โ‚น0.57 Billion85.93%
1999 -โ‚น0.31 Billion159.16%
1998 -โ‚น0.12 Billion85.71%
1997 -โ‚น62.89 Million-70.83%
1996 -โ‚น0.22 Billion-72.41%
1995 -โ‚น0.79 Billion-60.63%
1994 -โ‚น1.99 Billion45.39%
1993 -โ‚น1.37 Billion39.45%
1992 -โ‚น0.98 Billion-32.3%
1991 -โ‚น1.45 Billion6.62%
1990 -โ‚น1.36 Billion1577.78%
1989 -โ‚น80.86 Million-57.14%
1988 -โ‚น0.19 Billion-362.5%
1987 โ‚น71.86 M-130.77%
1986 -โ‚น0.24 Billion136.36%
1985 -โ‚น98.83 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novavax
NVAX
โ‚น33.68 B 1,334.44%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น61.02 B 2,498.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น52.39 B 2,130.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น921.63 B 39,143.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น637.47 B 27,044.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น721.65 B 30,628.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.064 T 45,237.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น10.38 B 342.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น9.8 Billion-517.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-โ‚น2 Billion-184.90%๐Ÿ‡บ๐Ÿ‡ธ USA